AnalystsKen CacciatoreKen Cacciatore's Stock Forecasts
AnalystsKen Cacciatore
Analyst Ranking
Bottom 9%
#4192 out of 4565 analysts
Average Return
-22.56%
Win Rate
23%3 out of 13
Risk vs Reward
Poor
Good
Ken Cacciatore's 5 best and worst ratings
Ken Cacciatore Analyst Color
Get additional color on Ken Cacciatore's coverage of popular stocks
Ken Cacciatore's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcutis Biotherapeutics IncARQT | 2 | Buy | $50.00 | +482.07% | Maintains | 9 months ago |
Takeda Pharmaceutical Co LtdTAK | 3 | Buy | $20.00 | +53.02% | Maintains | a year ago |
Scpharmaceuticals IncSCPH | 1 | Buy | $25.00 | N/A | Initiates Coverage On | a year ago |
Bausch & Lomb CorpBLCO | 1 | Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Molecular Partners AgMOLN | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 3 years ago |
Protara Therapeutics IncTARA | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 4 years ago |
Amarin Corp PLCAMRN | 1 | Buy | $23.00 | N/A | Initiates Coverage On | 4 years ago |
Iveric Bio IncISEE | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Optinose IncOPTN | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.